Dietary lactosucrose suppresses influenza A (H1N1) virus infection in mice

Abstract

This study examined the effects of lactosucrose (4G-β-D-galactosylsucrose) on influenza A virus infections in mice. First, the effects of lactosucrose on fermentation in the cecum and on immune function were investigated. In female BALB/c mice, lactosucrose supplementation for 6 weeks promoted cecal fermentation and increased both secretory IgA (SIgA) levels in feces and total IgA and IgG2a concentrations in serum. Both the percentage of CD4+ T cells in Peyer’s patches and the cytotoxic activity of splenic natural killer (NK) cells increased significantly in response to lactosucrose. Next, we examined the effects of lactosucrose on low-dose influenza A virus infection in mice. After 2 weeks of dietary supplementation with lactosucrose, the mice were infected with low-dose influenza A virus. At 7 days post infection, a comparison with control mice showed that weight loss was suppressed, as were viral titers in the lungs. In the spleens of lactosucrose-fed mice, there was an increase in the percentage of NK cells. Lastly, mice fed lactosucrose were challenged with a lethal dose of influenza A virus. The survival rate of these mice was significantly higher than that of mice fed a control diet. These results suggested that lactosucrose supplementation suppresses influenza A virus infection by augmenting innate immune responses and enhancing cellular and mucosal immunity.

Obesity as a risk factor for COVID-19: an overview

“…Metabolites are released from the gut microbiota, especially SCFAs such as acetate and butyrate, in addition to the anti-inflammatory cytokines linked to reduced pulmonary pathology in both bacterial (Bernard et al 2015;Vieira et al 2016) and viral infections (Kishino et al 2015). Galvão et al have shown that the absence of GPR43, a receptor for acetate, leads to increased susceptibility to Klebsiella pneumoniae infection, with uncontrolled proliferation of bacteria and to increased inflammatory response.…”

Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects

“…TLR stimulation by cell wall components and flagellin of gut microbiota is necessary for mounting the immune responses towards influenza. In contrast, oral SCFA-induced anti-inflammatory actions are attributed to decreased pulmonary pathology following bacterial and viral infections in mice ( 36 ). Effectively engaging PRRs expressing innate cells with gut- or non-microbial ligands is essential for the protective mechanism, independent of adaptive immunity during exposure to a pathogen or secondary infection.…”

Role of the Microbiome in Interstitial Lung Diseases

“…SCFAs are produced by many enteric bacterial species and act through free fatty acid (FFA) receptors or epigenetic regulation of immune cells to promote broad anti-inflammatory effects (56). SCFA administration is linked to reduced pulmonary pathology following both and viral and bacterial infection in mice (57)(58)(59). Overall, these studies suggest that recognition of the gut microbiota, as well as specific bacterial metabolites, primes the immune response to counter microbial challenges in the lung.…”